Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer

NCT00014469 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Graft Versus Host Disease
Leukemia
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Neoplasms

Interventions

DRUG: busulfan
DRUG: melphalan
DRUG: methotrexate
DRUG: tacrolimus
PROCEDURE: allogeneic bone marrow transplantation

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]